[Clinical and rheographic considerations on a new antiserotonin derivative (UML-491) with preventive action in hemicrania].
D000757:Anencephaly; D006261:Headache; D006801:Humans; D008238:Lysergic Acid Diethylamide; D008784:Methysergide; D008881:Migraine Disorders; D010992:Plethysmography, Impedance; D012701:Serotonin
D012701:Serotonin; D008238:Lysergic Acid Diethylamide; D008784:Methysergide
LYSERGIC ACID DIETHYLAMIDE; MIGRAINE; SEROTONIN